FGFR2 Peptide
€100.00
In stock
SKU
350468
Protein Family: Cell Adhesion Molecules, Cellular Antigens, Enzymes, Protein Kinases, Receptors and Channels
Pathway and Disease: Cancers, Cell Motility, Signal Transduction
Alternate Names: Fibroblast growth factor receptor 2; FGFR-2; Keratinocyte growth factor receptor 2; CD332 antigen; FGFR2; BEK; KGFR; KSAM
Accession No.: P21802, NP_000132
Description:
FGFR2 is a receptor for acidic and basic fibroblast growth factors. Defects in FGFR2 are the cause of numerous craniofacial abnormalities such as Crouzon, Jackson-Weiss, and Apert syndromes.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 1951.1 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200106 is selected from a sequence within the N-term region of human FGFR2. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C84H131N19O32S1
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Pathway and Disease: Cancers, Cell Motility, Signal Transduction
Alternate Names: Fibroblast growth factor receptor 2; FGFR-2; Keratinocyte growth factor receptor 2; CD332 antigen; FGFR2; BEK; KGFR; KSAM
Accession No.: P21802, NP_000132
Description:
FGFR2 is a receptor for acidic and basic fibroblast growth factors. Defects in FGFR2 are the cause of numerous craniofacial abnormalities such as Crouzon, Jackson-Weiss, and Apert syndromes.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 1951.1 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200106 is selected from a sequence within the N-term region of human FGFR2. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C84H131N19O32S1
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
| Is Featured? | No |
|---|
Write Your Own Review